Quantitative assessment of gliomas by proton magnetic resonance spectroscopy

Anticancer Research

Volumn 27, Issue 6 A, 2007, Pages 3757-3763

  Oshiro, Shinya ^a   Tsugu, Hitoshi ^a   Komatsu, Fuminari ^a   Abe, Hiroshi ^a   Onishi, Hirokazu ^a   Ohmura, Tadahiro ^a   Iwaasa, Mitsutoshi ^a   Sakamoto, Seisaburo ^a   Fukushima, Takeo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Diffusion; Glioma; Malignancy; Perfusion; Spectroscopy

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

ADULT; AGED; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS;

EID: 35349021418     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Felix R, Schoner W, Laniado M, Niendorf HP, Claussen C, Fiegler W and Speck LI: Brain tumors: MR imaging with gadolinium-DTPA. Radiology 156: 681-688, 1985.
2. Brant-Zawadzki M, Berry I, Osaki L, Brasch R, Murovic J and Norman D: Gd-DTPA in clinical MR of the brain: I. Intraaxial lesions. Am J Roentgenol 147: 1223-1230, 1986.
3. Dean BL, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW and Carey RG: Gliomas: classification with MR imaging. Radiology 174: 411-415, 1990.
4. Watanabe M, Tanaka R and Takeda N: Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34: 463-469, 1992.
5. Pierallini A, Bonamini M, Bozzao A, Pantano P, Stefano DD, Ferone E, Raguso M and Bosman C: Supratentorial diffuse astrocytic tumors: proposal of an MRI classification. Eur Radiol 7: 395-399, 1997.
6. Fayed N, Morales H, Modrego PJ and Pina MA: Contrast/noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminated low-grade from high-grade cerebral gliomas. Acad Radiol 13: 728-737, 2006.
7. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K and Zimmerman RA: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84: 449-458, 1996.
8. Preul MC, Caramanos Z, Collins L, Villemure JG, Leblanc R, Olivier A, Pokrupa R and Arnold DL: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance of spectroscopy. Nat Med 2: 323-325, 1996.
9. Herminghaus S, Dierks T, Pilatus U, Moller-Hartmann W, Wittsack J, Marquardt G, Labisch C, Lanfermann H, Schlote W and Zanella FE: Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 98: 74-81, 2003.
10. Magalhaes A, Godfrey W, Shen Y, Hu J and Smith W: Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Acad Radiol 12: 51-57, 2005.
11. 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry. Neuroradiology 48: 312-318, 2006.
12. Kleihues P, Burger PC and Scheithauer BW (eds.). Histological Typing of Tumors of the Central Nervous System. 2nd edition. Berlin, Springer-Verlag, pp. 11-20, 1993.
13. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW and Zagzag D: Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223: 11-29, 2002.
14. Yang D, Korogi Y, Sugahara T, Kitajima M, Shigematsu Y, Liang L, Ushio Y and Takahashi M: Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 44: 656-666, 2002.
15. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh V-A and Cotton F: Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48: 150-159, 2006.
16. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, Okuda T, Liang L, Ge Y, Komohara Y, Ushio Y and Takahashi M: Usefulness of diffusion-weighted MRI with echoplanar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9: 53-60, 1999.
17. Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV and Alger JR: Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50: 215-226, 2000.
18. Castillo M, Smith JK, Kwock L and Wilber K: Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22: 60-64, 2001.
19. Calvar JA, Meli FJ, Romero C, Calcagno ML, Yanez P, Martinez AR, Lambre H, Taratuto AL and Sevlever G: Characterization of brain tumors by MRS, DWI and Ki-67 labeling index. J Neurooncol 72: 273-280, 2005.
20. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA and Zagzag D: Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 24: 1989-1998, 2003.
21. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S and Akalin T: Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 58: 394-403, 2006.
22. Fayed N and Modrego PJ: The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumors. J Neurooncol 72: 261-265, 2005.
23. Izumiyama H, Abe T, Tanioka D, Fukuda A and Kunii N: Clinicopathological examination of glioma by proton magnetic resonance spectroscopy background. Brain Tumor Pathol 21: 39-46, 2004.
24. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR and Di Chiro G: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87: 516-524, 1997.
25. Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U and Zanella FE: Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44: 371-381, 2002.
26. Fountas KN, Kapsalaki EZ, Vogel RL, Fezoulidis I, Robinson JS and Gotsis ED: Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 82: 90-97, 2004.
27. Matsumura A, Isobe T, Anno I, Takano S and Kawamura H: Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 12: 416-420, 2005.
28. Catalaa I, Henry R, Dillon WP, Graves EE, Mcknight TR, Lu Y, Vigneron DB and Nelson SJ: Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed 19: 463-475, 2006.